The alterations of cerebrospinal fluid TNF-alpha and TGF-beta2 levels in early relapsing–remitting multiple sclerosis.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 708, doi. 10.1007/s12026-022-09303-x
- By:
- Publication type:
- Article
Works matching IS 0257277X AND DT 2022 AND VI 70 AND IP 5
Results: 14
1
2
Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 698, doi. 10.1007/s12026-022-09302-y
- By:
- Publication type:
- Article
3
Tryptanthrin attenuates TLR3-mediated STAT1 activation in THP-1 cells.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 688, doi. 10.1007/s12026-022-09301-z
- By:
- Publication type:
- Article
4
Hydroquinone predisposes for retinal pigment epithelial (RPE) cell degeneration in inflammatory conditions.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 678, doi. 10.1007/s12026-022-09300-0
- By:
- Publication type:
- Article
5
The ability of inflammatory markers to recognize infection in cancer patients with fever at admission.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 667, doi. 10.1007/s12026-022-09299-4
- By:
- Publication type:
- Article
6
Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet's disease.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 654, doi. 10.1007/s12026-022-09298-5
- By:
- Publication type:
- Article
7
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management.
- Published in:
- 2022
- By:
- Publication type:
- Letter
8
Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 644, doi. 10.1007/s12026-022-09296-7
- By:
- Publication type:
- Article
9
High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 633, doi. 10.1007/s12026-022-09295-8
- By:
- Publication type:
- Article
10
Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 607, doi. 10.1007/s12026-022-09290-z
- By:
- Publication type:
- Article
11
Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 578, doi. 10.1007/s12026-022-09286-9
- By:
- Publication type:
- Article
12
Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 566, doi. 10.1007/s12026-022-09285-w
- By:
- Publication type:
- Article
13
Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 714, doi. 10.1007/s12026-022-09269-w
- By:
- Publication type:
- Article
14
Livin promotes Th2-type immune response in airway allergic diseases.
- Published in:
- Immunologic Research, 2022, v. 70, n. 5, p. 624, doi. 10.1007/s12026-022-09294-9
- By:
- Publication type:
- Article